Germline RBBP6 mutations in familial myeloproliferative neoplasms.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Blood

• Publication date

  2016-01-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2015-09-668673PMID 26574608PMCID PMC5043418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

  2015cited by this paper
• Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasms.

  2014cited by this paper
• CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.

  2014cited by this paper
• Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms

  2014cited by this paper
• The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms

  2014cited by this paper
• Looking for CALR mutations in familial myeloproliferative neoplasms

  2014cited by this paper
• Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

  2013cited by this paper
• Somatic mutations of calreticulin in myeloproliferative neoplasms.

  2013cited by this paper
• High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk Acute Myeloid Leukemia (AML)

  2012cited by this paper
• The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms

  2011cited by this paper
• DNMT3A mutations in acute myeloid leukemia.

  2010cited by this paper
• Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms.

  2009cited by this paper
• Mutations of ASXL1 gene in myeloproliferative neoplasms

  2009cited by this paper
• Mutation in TET2 in myeloid cancers.

  2009cited by this paper
• A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

  2009cited by this paper
• Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.

  2008cited by this paper
• PACT is a negative regulator of p53 and essential for cell growth and embryonic development

  2007cited by this paper
• JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders

  2006cited by this paper
• Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders.

  2006cited by this paper
• MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

  2006cited by this paper
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

  2005cited by this paper
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

  2005cited by this paper
• A gain-of-function mutation of JAK2 in myeloproliferative disorders.

  2005cited by this paper
• Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease.

  2003cited by this paper
• Germline p16 mutations in familial melanoma

  1994cited by this paper
• Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.

  1990cited by this paper
• Human retinoblastoma susceptibility gene: cloning, identification, and sequence

  1987cited by this paper

• Genetic variants in NHEJ1 and related DNA repair disorders: insights into phenotypic heterogeneity and links to hypoplastic myelodysplastic syndromes and familial hematological malignancies susceptibility

  2025cites this paper
• JAK2 46/1 (GGCC) Haplotype in Oncogenesis, as Risk Stratifier, and Indicator for Drug Resistance in Myeloproliferative Neoplasms

  2025cites this paper
• Yellow Fever Virus Interactomes Reveal Common and Divergent Strategies of Replication and Evolution for Mosquito-borne Flaviviruses

  2025cites this paper
• Evaluation of the ATM L2307F germline variant in 121 Italian pedigrees with familial myeloproliferative neoplasms

  2024cites this paper
• Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes.

  2024cites this paper
• Prospective genetic germline evaluation in a consecutive group of adult patients aged <60 years with myelodysplastic syndromes

  2024cites this paper
• Modulation of diverse biological processes by CPSF, the master regulator of mRNA 3′ ends

  2024cites this paper
• Mutations, inflammation and phenotype of myeloproliferative neoplasms

  2023cites this paper
• BCR::ABL1 negative myeloproliferative neoplasms: A review focused on essential thrombocythemia and polycythemia vera.

  2023cites this paper
• Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms

  2023cites this paper
• The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency

  2023cites this paper
• Familial essential thrombocythemia: 6 cases from a mono‐institutional series

  2022cites this paper
• Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms

  2022cites this paper
• Genetic basis and molecular profiling in myeloproliferative neoplasms

  2022cites this paper
• CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk

  2022cites this paper
• The roles of sex and genetics in the MPN.

  2022cites this paper
• Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology.

  2021cites this paper
• The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome

  2021cites this paper
• Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms.

  2021cites this paper
• Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms

  2021cites this paper
• Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms

  2021cites this paper
• Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera

  2021influential citation
• New progress in the study of germline susceptibility genes of myeloid neoplasms

  2021influential citation
• Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.

  2020cites this paper
• Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.

  2020cites this paper
• Aetiology of Myeloproliferative Neoplasms

  2020cites this paper
• Advances in germline predisposition to acute leukaemias and myeloid neoplasms

  2020cites this paper
• Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities

  2020cites this paper
• Myeloproliferative and lymphoproliferative disorders: State of the art

  2019cites this paper
• Diagnostic workflow for hereditary erythrocytosis and thrombocytosis.

  2019cites this paper
• Inherited and Acquired Myeloid Neoplasms of Childhood

  2018cites this paper
• Neoplastische Bildungsstörungen der Hämatopoiese mit Ausreifungsverlust

  2018cites this paper
• Germ line predisposition to myeloid malignancies appearing in adulthood

  2018cites this paper
• Myeloproliferative Neoplasms in Danish Twins

  2018cites this paper
• Recognition of familial myeloid neoplasia in adults.

  2017cites this paper
• Myeloproliferative neoplasms: from origins to outcomes.

  2017cites this paper
• Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms.

  2017cites this paper
• Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms

  2017cites this paper
• Myeloid neoplasms with germline DDX41 mutation

  2017cites this paper
• Buccal epithelial cells display somatic, bone marrow-derived CALR mutation.

  2017cites this paper
• Advances in understanding the pathogenesis of familial myeloproliferative neoplasms

  2017cites this paper
• Familial MPN Predisposition

  2017cites this paper
• MYELOPROLIFERATIVE NEOPLASMS Diagnosis , risk strati fi cation , and response evaluation in classical myeloproliferative neoplasms

  2017cites this paper
• State of the Art Update and Next Questions: Acute Myeloid Leukemia

  2017cites this paper
• Myeloproliferative neoplasms: from origins to outcomes.

  2017cites this paper
• Genomics of Myeloproliferative Neoplasms.

  2017cites this paper
• Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

  2017cites this paper
• Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.

  2017cites this paper
• Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera

  2017influential citation
• [Not Available].

  2016cites this paper
• Aspects biologiques de la voie JAK/STAT dans les néoplasmes myéloprolifératifs classiques négatifs pour BCR-ABL

  2016cites this paper
• Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists

  2016cites this paper
• Germ line mutations associated with leukemias.

  2016cites this paper
• Genetic predisposition to leukemia and other hematologic malignancies.

  2016cites this paper
• LNK mutations in familial myeloproliferative neoplasms.

  2016cites this paper
• Survival in patients with familial and sporadic myeloproliferative neoplasms.

  2015cites this paper
• The Drosophila Retinoblastoma Binding Protein 6 Family Member Has Two Isoforms and Is Potentially Involved in Embryonic Patterning

  2015cites this paper
• JAK2 46/1 (GGCC) Haplotype: A Biomarker for Oncogenesis, Risk Stratification, and Drug Resistance in Myeloproliferative Neoplasms

  year unknowncites this paper